0
Editorials |

Epoprostenol Therapy as a Bridge to Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension

Kim M. Kerr, MD, FCCP; Lewis J. Rubin, MD, FCCP
Author and Funding Information

Affiliations: La Jolla, CA
 ,  Dr. Kerr is Assistant Professor of Medicine and Dr. Rubin is Professor of Medicine, Pulmonary Vascular Center and Division of Pulmonary and Critical Care Medicine, University of California, San Diego, School of Medicine.

Correspondence to: Lewis J. Rubin, MD, FCCP, Pulmonary Vascular Center and Division of Pulmonary and Critical Care Medicine, University of California, San Diego, School of Medicine, 9300 Campus Point Dr, La Jolla, CA 92037; e-mail: ljrubin@ucsd.edu



Chest. 2003;123(2):319-320. doi:10.1378/chest.123.2.319
Text Size: A A A
Published online

Extract

Despite major advances in the medical treatment of chronic pulmonary artery hypertension, only one form of this condition is potentially curable. At experienced centers, the performance of pulmonary thromboendarterectomy (PTE) for the treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH) results in restoration of normal or near-normal pulmonary hemodynamics, even in the presence of severe pulmonary hypertension or right-sided heart failure.12 The risk of recurrence is low, since patients generally have preoperative placement of an inferior vena cava filter and are treated indefinitely with oral anticoagulants once surgery has been performed.3

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543